7,12-Dihydroxy-9-methoxy-2,2-dimethyl-10-(3-methylbut-2-en-1-yl)-2H,6H-pyrano[3,2-b]xanthen-6-one

Catalog No. :
ACAICQ866
CAS No. :
864516-31-4
Molecular Formula :
C24H24O6
Molecular Weight :
408.45

IUPAC Name:7,12-dihydroxy-9-methoxy-2,2-dimethyl-10-(3-methylbut-2-en-1-yl)-2H,6H-pyrano[3,2-b]xanthen-6-one

7,12-Dihydroxy-9-methoxy-2,2-dimethyl-10-(3-methylbut-2-en-1-yl)-2H,6H-pyrano[3,2-b]xanthen-6-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7,12-Dihydroxy-9-methoxy-2,2-dimethyl-10-(3-methylbut-2-en-1-yl)-2H,6H-pyrano[3,2-b]xanthen-6-one
IUPAC Name7,12-dihydroxy-9-methoxy-2,2-dimethyl-10-(3-methylbut-2-en-1-yl)-2H,6H-pyrano[3,2-b]xanthen-6-one
Molecular FormulaC24H24O6
Molecular Weight408.45
SMILESO=C1C2=C(OC3=C1C(O)=CC(OC)=C3CC=C(C)C)C(O)=C4C(C=CC(C)(C)O4)=C2
InChI KeyOCYZJBDJUYIHMM-UHFFFAOYSA-N
SynonymNigrolineaxanthone V;7,12-Dihydroxy-9-methoxy-2,2-dimethyl-10-(3-methyl-2-buten-1-yl)-2H,6H-pyrano[3,2-b]xanthene-6-one;2H,6H-Pyrano[3,2-b]xanthene-6-one, 7,12-dihydroxy-9-methoxy-2,2-dimethyl-10-(3-methyl-2-buten-1-yl)-
CAS No.864516-31-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACAICQ866 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAICQ866 route product structure diagram
    ACAICQ866864516-31-4
Inquiry

2. ACAICQ866 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAICQ866 route product structure diagram
    ACAICQ866864516-31-4
Inquiry

Comments (0)